Verified peer comparison
MEDIFAST vs Sinovac Biotech Financial Comparison
Direct answer
MEDIFAST and Sinovac Biotech are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free MEDIFAST email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- MEDIFAST Revenue
- 385,788,000 USD
- Sinovac Biotech Revenue
- 386,013,000 USD
- MEDIFAST Operating income
- -14,213,000 USD
- Sinovac Biotech Operating income
- -291,322,000 USD